These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 30430949)

  • 1. Extending Arms of Insulin Resistance from Diabetes to Alzheimer's Disease: Identification of Potential Therapeutic Targets.
    Gupta S; Singhal NK; Ganesh S; Sandhir R
    CNS Neurol Disord Drug Targets; 2019; 18(3):172-184. PubMed ID: 30430949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin signaling: An opportunistic target to minify the risk of Alzheimer's disease.
    Pardeshi R; Bolshette N; Gadhave K; Ahire A; Ahmed S; Cassano T; Gupta VB; Lahkar M
    Psychoneuroendocrinology; 2017 Sep; 83():159-171. PubMed ID: 28624654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type 3 Diabetes and Its Role Implications in Alzheimer's Disease.
    Nguyen TT; Ta QTH; Nguyen TKO; Nguyen TTD; Giau VV
    Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32365816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes mellitus and Alzheimer's disease: GSK-3β as a potential link.
    Zhang Y; Huang NQ; Yan F; Jin H; Zhou SY; Shi JS; Jin F
    Behav Brain Res; 2018 Feb; 339():57-65. PubMed ID: 29158110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of diet- and genetically-induced brain insulin resistance on amyloid pathology in a mouse model of Alzheimer's disease.
    Wakabayashi T; Yamaguchi K; Matsui K; Sano T; Kubota T; Hashimoto T; Mano A; Yamada K; Matsuo Y; Kubota N; Kadowaki T; Iwatsubo T
    Mol Neurodegener; 2019 Apr; 14(1):15. PubMed ID: 30975165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Streptozotocin Intracerebroventricular-Induced Neurotoxicity and Brain Insulin Resistance: a Therapeutic Intervention for Treatment of Sporadic Alzheimer's Disease (sAD)-Like Pathology.
    Kamat PK; Kalani A; Rai S; Tota SK; Kumar A; Ahmad AS
    Mol Neurobiol; 2016 Sep; 53(7):4548-62. PubMed ID: 26298663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's Disease and Diabetes: Insulin Signaling as the Bridge Linking Two Pathologies.
    Shieh JC; Huang PT; Lin YF
    Mol Neurobiol; 2020 Apr; 57(4):1966-1977. PubMed ID: 31900863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Insulin Degrading Enzyme and Neprilysin in Alzheimer's Disease Biology: Characterization of Putative Cognates for Therapeutic Applications.
    Jha NK; Jha SK; Kumar D; Kejriwal N; Sharma R; Ambasta RK; Kumar P
    J Alzheimers Dis; 2015; 48(4):891-917. PubMed ID: 26444774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
    Chen Z; Zhong C
    Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin resistance and Alzheimer's disease: molecular links & clinical implications.
    Neumann KF; Rojo L; Navarrete LP; Farías G; Reyes P; Maccioni RB
    Curr Alzheimer Res; 2008 Oct; 5(5):438-47. PubMed ID: 18855585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TLR4 is a link between diabetes and Alzheimer's disease.
    Huang NQ; Jin H; Zhou SY; Shi JS; Jin F
    Behav Brain Res; 2017 Jan; 316():234-244. PubMed ID: 27591966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron metabolism in diabetes-induced Alzheimer's disease: a focus on insulin resistance in the brain.
    Chung JY; Kim HS; Song J
    Biometals; 2018 Oct; 31(5):705-714. PubMed ID: 30043289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is Alzheimer's disease a Type 3 Diabetes? A critical appraisal.
    Kandimalla R; Thirumala V; Reddy PH
    Biochim Biophys Acta Mol Basis Dis; 2017 May; 1863(5):1078-1089. PubMed ID: 27567931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuronal stress signaling and eIF2α phosphorylation as molecular links between Alzheimer's disease and diabetes.
    Lourenco MV; Ferreira ST; De Felice FG
    Prog Neurobiol; 2015 Jun; 129():37-57. PubMed ID: 25857551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central insulin dysregulation and energy dyshomeostasis in two mouse models of Alzheimer's disease.
    Velazquez R; Tran A; Ishimwe E; Denner L; Dave N; Oddo S; Dineley KT
    Neurobiol Aging; 2017 Oct; 58():1-13. PubMed ID: 28688899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of neuronal insulin/insulin-like growth factor-1 signaling for the pathogenesis of Alzheimer's disease: possible therapeutic implications.
    Zemva J; Schubert M
    CNS Neurol Disord Drug Targets; 2014 Mar; 13(2):322-37. PubMed ID: 24059318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in insulin and insulin signaling in Alzheimer's disease: cause or consequence?
    Stanley M; Macauley SL; Holtzman DM
    J Exp Med; 2016 Jul; 213(8):1375-85. PubMed ID: 27432942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of Diabetes: a Therapeutic Strategy for Alzheimer's Disease?
    Ahn KC; Learman CR; Baker GB; Weaver CL; Chung PS; Kim HG; Song MS
    J Korean Med Sci; 2019 Dec; 34(46):e297. PubMed ID: 31779058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of insulin and neurotrophic factor signaling in brain aging and Alzheimer's Disease.
    Cole GM; Frautschy SA
    Exp Gerontol; 2007; 42(1-2):10-21. PubMed ID: 17049785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DPP-4 Inhibitor Linagliptin Attenuates Aβ-induced Cytotoxicity through Activation of AMPK in Neuronal Cells.
    Kornelius E; Lin CL; Chang HH; Li HH; Huang WN; Yang YS; Lu YL; Peng CH; Huang CN
    CNS Neurosci Ther; 2015 Jul; 21(7):549-57. PubMed ID: 26010513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.